Journal article
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis
Abstract
BACKGROUND & AIMS: Comparative effectiveness studies are needed to help position therapies for ulcerative colitis (UC). We compared the efficacy of infliximab vs vedolizumab for moderate to severe biologic-naïve UC using patient-level data from clinical trial program data sets.
METHODS: This was a post hoc analysis of 3 UC clinical trial programs that included data on 795 biologic-naïve UC patients. Differences in proportions of patients …
Authors
Narula N; Wong ECL; Marshall JK; Colombel J-F; Dulai PS; Reinisch W
Journal
Clinical Gastroenterology and Hepatology, Vol. 20, No. 7, pp. 1588–1597.e3
Publisher
Elsevier
Publication Date
July 2022
DOI
10.1016/j.cgh.2021.07.038
ISSN
1542-3565